BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37288821)

  • 1. Antibody-mediated inhibition of tissue-type plasminogen activator binding to the low-density lipoprotein receptor-related protein 1 as a potential beneficial modulator for stroke therapy.
    Klecker PH; Fritzen L; Mazura AD; Weggen S; Pietrzik CU
    J Cell Biochem; 2023 Jul; 124(7):1040-1049. PubMed ID: 37288821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.
    Zhang C; An J; Strickland DK; Yepes M
    Am J Pathol; 2009 Feb; 174(2):586-94. PubMed ID: 19147818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
    Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
    Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
    Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models.
    Qiu L; Cai Y; Geng Y; Yao X; Wang L; Cao H; Zhang X; Wu Q; Kong D; Ding D; Shi Y; Wang Y; Wu J
    Acta Biomater; 2022 Dec; 154():424-442. PubMed ID: 36367475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology.
    Gonias SL; Banki MA; Gilder AS; Azmoon P; Campana WM; Mantuano E
    J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29930084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.
    Adibhatla RM; Hatcher JF
    CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):243-53. PubMed ID: 18673209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRP1 assembles unique co-receptor systems to initiate cell signaling in response to tissue-type plasminogen activator and myelin-associated glycoprotein.
    Mantuano E; Lam MS; Gonias SL
    J Biol Chem; 2013 Nov; 288(47):34009-34018. PubMed ID: 24129569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke.
    Yao SQ; Ye Y; Li Q; Wang XY; Yan L; Huo XM; Pan CS; Fu Y; Liu J; Han JY
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117024. PubMed ID: 37572928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells ameliorate tissue plasminogen activator-induced brain haemorrhage after stroke.
    Mao L; Li P; Zhu W; Cai W; Liu Z; Wang Y; Luo W; Stetler RA; Leak RK; Yu W; Gao Y; Chen J; Chen G; Hu X
    Brain; 2017 Jul; 140(7):1914-1931. PubMed ID: 28535201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
    Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1 receptor-mediated endogenous tPA upregulation contributes to blood-brain barrier injury after acute ischaemic stroke.
    Wang Y; Wang X; Zhang X; Chen S; Sun Y; Liu W; Jin X; Zheng G
    J Cell Mol Med; 2020 Aug; 24(16):9255-9266. PubMed ID: 32627929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke.
    Wang R; Zhu Y; Liu Z; Chang L; Bai X; Kang L; Cao Y; Yang X; Yu H; Shi MJ; Hu Y; Fan W; Zhao BQ
    Blood; 2021 Jul; 138(1):91-103. PubMed ID: 33881503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis.
    Benchenane K; Berezowski V; Ali C; Fernández-Monreal M; López-Atalaya JP; Brillault J; Chuquet J; Nouvelot A; MacKenzie ET; Bu G; Cecchelli R; Touzani O; Vivien D
    Circulation; 2005 May; 111(17):2241-9. PubMed ID: 15851587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
    Li Y; Zhu ZY; Lu BW; Huang TT; Zhang YM; Zhou NY; Xuan W; Chen ZA; Wen DX; Yu WF; Li PY
    CNS Neurosci Ther; 2019 Dec; 25(12):1343-1352. PubMed ID: 31756041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
    Yepes M; Sandkvist M; Moore EG; Bugge TH; Strickland DK; Lawrence DA
    J Clin Invest; 2003 Nov; 112(10):1533-40. PubMed ID: 14617754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
    Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
    Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoflurane Postconditioning Inhibits tPA-Induced Matrix Metalloproteinases Activation After Hypoxic Injury via Low-Density Lipoprotein Receptor-Related Protein and Extracellular Signal-Regulated Kinase Pathway.
    Kim SY; Cheon SY; Kim EJ; Lee JH; Kam EH; Kim JM; Park M; Koo BN
    Neurochem Res; 2017 May; 42(5):1533-1542. PubMed ID: 28303501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.